GT Biopharma (OXISD) Announces Development Plan For Non-Opioid Neuropathic Pain Treatment “PainBrake” GT Biopharma Inc. announced today that it has made the required payment to license and develop PainBrake, a non-opioid pain medication, to Accu-Break Pharmaceuticals Inc. The payment allows GT Biopharma (OTCQB: OXISD) to begin the clinical development process and the filing of a
Complete Reading

YELLEN MAINTAINS PLAN TO HIKE INTEREST RATES, SHRINK BALANCE SHEET FOREX INVESTORS BUZZ INTEREST RATES   Federal Reserve Chair Janet Yellen said Wednesday that the U.S. central bank remains on track to both raise interest rates and begin shrinking its balance sheet before the end of the year. In prepared remarks released before her testimony
Complete Reading

Cryptobuyer installed the first Bitcoin ATMs in a commercial bank as it announced plans for expansion, ICO, and the new Blockchain Academy Latam. BUZ INVESTORS  PRESS RELEASE  Cryptobuyer Emerges as a Leader  Cryptobuyer, a leading cryptocurrency and digital assets company in the Latin America has gained the distinction of being the first company ever to
Complete Reading

Chart | Calendar   | TRADE NOW | healthcare Voters Disapprove Of GOP Healthcare Bill, Trump Tax Plan BUZ INVESTORS  GOP Healthcare Bill Repealing and replacing Obamacare and reforming the tax code are two of President Donald Trump’s top priorities, but the results of a Quinnipiac University national poll show weak support for the proposals backed by
Complete Reading

Chart | Calendar   | TRADE NOW | therapeutics TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch BUZ INVESTORS  IMMU Soars  Today’s Daily Dose brings you news about the much awaited regulatory event of TherapeuticsMD; strategic plan devised by Immunomedics; the next business milestone of Agile and news about Teva’s CONCERTO trial.
Complete Reading

Create Account



Log In Your Account